Photocure ASA

Photocure ASA: Invitation to presentation of 4th quarter and preliminary full year 2024 financial results

Oslo, Norway, 12 February 2025: Photocure ASA (Photocure, PHO: OSE) will

announce the fourth quarter and preliminary full year 2024 financial results on

Wednesday 19 February 2025 at 08:00 CET and will present a live webcast at 14:00

CET the same day.

The quarterly report and presentation will be published at 08:00 CET and will be

publicly available at www.photocure.com.

The investor presentation will be streamed live and be hosted by Dan Schneider,

CEO and Erik Dahl, CFO. The presentation will be held in English and questions

can be submitted throughout the event. The presentation is scheduled to conclude

at 14:45 CET.

The streaming event is available through

https://channel.royalcast.com/landingpage/hegnarmedia/20250219_4/ (https://eur01.

safelinks.protection.outlook.com/?url=https%3A%2F%2Fchannel.royalcast.com%2Flandi

ngpage%2Fhegnarmedia%2F20250219_4%2F&data=05%7C02%7CTH%40photocure.no%7C2adf5235f

d004e8cdb8208dd39e26352%7C0986794f1d6f488980bd853c0715d3c1%7C0%7C0%7C638730366687

486130%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOi

JXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=SdQGIGU%2B5o1Tm3aUc

jdMtjlgCFH1e9dFEI4J71FBcL0%3D&reserved=0)

For further information, please contact:

Photocure

Erik Dahl

CFO

Tel: +47 45055000

David Moskowitz

Vice President, Investor Relations

Tel: +1 202 280 0888

Media and IR enquiries:

Geir Bjørlo

Corporate Communications (Norway)

Tel: +47 91540000

About Photocure

Photocure: The Bladder Cancer Company delivers transformative solutions to

improve the lives of bladder cancer patients. Our unique technology, making

cancer cells glow bright pink, has led to better health outcomes for patients

worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo

Stock Exchange (OSE: PHO). For more information, please visit us at

www.photocure.com and www.cysview.com.

This information is subject to the disclosure requirements pursuant to section 5

-12 of the Norwegian Securities Trading Act.

AI Terminal